Sepracor Insomnia Drug Awarded to McCann

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK Sepracor has assigned creative duties on its $50 million Estorra account to McCann-Erickson after a six-week review, sources said.

Interpublic Group’s McCann here beat out Omnicom Group’s Merkley Newman Harty & Partners, also in New York, to pick up the insomnia drug. McCann unit Torre Lazur-McCann Healthcare in Parsippany, N.J., already handles professional advertising on the brand. McCann’s effort will be for the first direct-to-consumer campaign for Estorra.

IPG’s Initiative Media will handle media chores, sources said.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in